» Articles » PMID: 18755840

Mir-302 Reprograms Human Skin Cancer Cells into a Pluripotent ES-cell-like State

Overview
Journal RNA
Specialty Molecular Biology
Date 2008 Aug 30
PMID 18755840
Citations 217
Authors
Affiliations
Soon will be listed here.
Abstract

Renewal of stem cells differs from cancer cell growth in self-controlled cell division. The mir-302 microRNA (miRNA) family (mir-302s) is expressed most abundantly in slow-growing human embryonic stem (ES) cells, and quickly decreases after cell differentiation and proliferation. Therefore, mir-302s was investigated as one of the key factors essential for maintenance of ES cell renewal and pluripotency in this study. The Pol-II-based intronic miRNA expression system was used to transgenically transfect the mir-302s into several human cancer cell lines. The mir-302-transfected cells, namely, miRNA-induced pluripotent stem (mirPS) cells, not only expressed many key ES cell markers, such as Oct3/4, SSEA-3, SSEA-4 ,Sox2, and Nanog, but also had a highly demethylated genome similar to a reprogrammed zygotic genome. Microarray analyses further revealed that genome-wide gene expression patterns between the mirPS and human ES H1 and H9 cells shared over 86% similarity. Using molecular guidance in vitro, these mirPS cells could differentiate into distinct tissue cell types, such as neuron-, chondrocyte-, fibroblast-, and spermatogonia-like primordial cells. Based on these findings, we conclude that mir-302s not only function to reprogram cancer cells into an ES-like pluripotent state but also to maintain this state under a feeder-free cultural condition, which may offer a great opportunity for therapeutic intervention.

Citing Articles

CHIR99021 and Brdu Are Critical in Chicken iPSC Reprogramming via Small-Molecule Screening.

Jin K, Zhou J, Wu G, Li Z, Zhu X, Liang Y Genes (Basel). 2024; 15(9).

PMID: 39336797 PMC: 11431361. DOI: 10.3390/genes15091206.


Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles.

Ten A, Kumeiko V, Farniev V, Gao H, Shevtsov M Cells. 2024; 13(8.

PMID: 38667297 PMC: 11049026. DOI: 10.3390/cells13080682.


Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine.

Inagaki M J Dev Biol. 2024; 12(1).

PMID: 38535481 PMC: 10971469. DOI: 10.3390/jdb12010001.


Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer.

Marks M, Gimenez C, Isaja L, Vera M, Borzone F, Pereyra-Bonnet F J Cancer Res Clin Oncol. 2024; 150(2):106.

PMID: 38418798 PMC: 10902018. DOI: 10.1007/s00432-024-05607-7.


The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review).

Pensotti A, Bizzarri M, Bertolaso M Oncol Rep. 2024; 51(3).

PMID: 38275101 PMC: 10835663. DOI: 10.3892/or.2024.8707.


References
1.
Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

2.
Xia X, Zhou H, Samper E, Melov S, Xu Z . Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice. PLoS Genet. 2006; 2(1):e10. PMC: 1358942. DOI: 10.1371/journal.pgen.0020010. View

3.
Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K . In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151):318-24. DOI: 10.1038/nature05944. View

4.
Danin-Kreiselman M, Lee C, Chanfreau G . RNAse III-mediated degradation of unspliced pre-mRNAs and lariat introns. Mol Cell. 2003; 11(5):1279-89. DOI: 10.1016/s1097-2765(03)00137-0. View

5.
Rodriguez A, Griffiths-Jones S, Ashurst J, Bradley A . Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004; 14(10A):1902-10. PMC: 524413. DOI: 10.1101/gr.2722704. View